Stocks › WST

WEST PHARMACEUTICAL SERVICES INC

WST·NYSE·United States United States·USD
$390.30
-6.39 (-1.61%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
WST
WEST PHARMACEUTICAL SERVICES INC · NYSE
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
WSTS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of WST by members of U.S. Congress · 76 on record · 4 in the last 12 months
All congressional trades →
PoliticianStockTypeFiledTraded
Ro KhannaRo KhannaHouse · D · CA WSTWEST PHARMACEUTICAL SERVICES INC · Common Stock Sale
$1,001 - $15,000
Jul 7, 2026 Jun 2, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA WSTWEST PHARMACEUTICAL SERVICES INC · Common Stock Sale
$1,001 - $15,000
Jun 10, 2026 May 27, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA WSTWEST PHARMACEUTICAL SERVICES INC · Common Stock Sale
$1,001 - $15,000
Mar 9, 2026 Feb 5, 2026 Filing ↗
Ro KhannaRo KhannaHouse · D · CA WSTWEST PHARMACEUTICAL SERVICES INC · Stock Purchase
$1,001 - $15,000
Feb 6, 2026 Jan 29, 2026 Filing ↗
Lisa C. McClainLisa C. McClainHouse · R · MI WSTWEST PHARMACEUTICAL SERVICES INC · Stock Sale
$1,001 - $15,000
Aug 13, 2025 Jul 22, 2025 Filing ↗
Lisa C. McClainLisa C. McClainHouse · R · MI WSTWEST PHARMACEUTICAL SERVICES INC · Stock Purchase
$1,001 - $15,000
Aug 13, 2025 Jun 17, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA WSTWEST PHARMACEUTICAL SERVICES INC · Stock Purchase
$1,001 - $15,000
Jun 10, 2025 May 19, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA WSTWEST PHARMACEUTICAL SERVICES INC · Common Stock Purchase
$1,001 - $15,000
May 12, 2025 Apr 23, 2025 Filing ↗
Robert P. Bresnahan, Jr.Robert P. Bresnahan, Jr.House · R · PA WSTWEST PHARMACEUTICAL SERVICES INC · Stock Sale
$1,001 - $15,000
May 8, 2025 Apr 8, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA WSTWEST PHARMACEUTICAL SERVICES INC · Common Stock Sale
$1,001 - $15,000
Apr 10, 2025 Mar 12, 2025 Filing ↗
Robert P. Bresnahan, Jr.Robert P. Bresnahan, Jr.House · R · PA WSTWEST PHARMACEUTICAL SERVICES INC · Stock Purchase
$1,001 - $15,000
Mar 27, 2025 Feb 25, 2025 Filing ↗
Jared MoskowitzJared MoskowitzHouse · D · FL WSTWEST PHARMACEUTICAL SERVICES INC · Stock Sale
$1,001 - $15,000
Mar 6, 2025 Feb 13, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA WSTWEST PHARMACEUTICAL SERVICES INC · Common Stock Sale
$1,001 - $15,000
Mar 6, 2025 Feb 19, 2025 Filing ↗
Ro KhannaRo KhannaHouse · D · CA WSTWEST PHARMACEUTICAL SERVICES INC · Common Stock Purchase
$1,001 - $15,000
Jan 8, 2025 Dec 16, 2024 Filing ↗
Jared MoskowitzJared MoskowitzHouse · D · FL WSTWEST PHARMACEUTICAL SERVICES INC · Stock Sale
$1,001 - $15,000
Dec 9, 2024 Nov 8, 2024 Filing ↗
Ro KhannaRo KhannaHouse · D · CA WSTWEST PHARMACEUTICAL SERVICES INC · CMN Sale
$1,001 - $15,000
Nov 8, 2024 Oct 11, 2024 Filing ↗
Ro KhannaRo KhannaHouse · D · CA WSTWEST PHARMACEUTICAL SERVICES INC · Stock Purchase
$1,001 - $15,000
Nov 8, 2024 Oct 14, 2024 Filing ↗
Ro KhannaRo KhannaHouse · D · CA WSTWEST PHARMACEUTICAL SERVICES INC · Common Stock Sale
$1,001 - $15,000
Oct 4, 2024 Sep 9, 2024 Filing ↗
Ro KhannaRo KhannaHouse · D · CA WSTWEST PHARMACEUTICAL SERVICES INC · Common Stock Purchase
$1,001 - $15,000
Oct 4, 2024 Sep 9, 2024 Filing ↗
Ro KhannaRo KhannaHouse · D · CA WSTWEST PHARMACEUTICAL SERVICES INC · Common Stock Sale
$1,001 - $15,000
Oct 4, 2024 Sep 9, 2024 Filing ↗
Ro KhannaRo KhannaHouse · D · CA WSTWEST PHARMACEUTICAL SERVICES INC · CMN Sale
$1,001 - $15,000
Sep 6, 2024 Aug 2, 2024 Filing ↗
Ro KhannaRo KhannaHouse · D · CA WSTWEST PHARMACEUTICAL SERVICES INC · Common Stock Purchase
$1,001 - $15,000
Sep 6, 2024 Aug 2, 2024 Filing ↗
Ro KhannaRo KhannaHouse · D · CA WSTWEST PHARMACEUTICAL SERVICES INC · Common Stock Purchase
$1,001 - $15,000
Sep 6, 2024 Aug 5, 2024 Filing ↗
Jared MoskowitzJared MoskowitzHouse · D · FL WSTWEST PHARMACEUTICAL SERVICES INC · Stock Purchase
$1,001 - $15,000
Aug 21, 2024 Jul 14, 2023 Filing ↗
Jared MoskowitzJared MoskowitzHouse · D · FL WSTWEST PHARMACEUTICAL SERVICES INC · Stock Purchase
$1,001 - $15,000
Aug 21, 2024 Dec 28, 2023 Filing ↗

Whale Activity

Position changes in WST reported for 2026-09-30 by 944 institutional filers
Increased: 306New: 123Held: 128Decreased: 290Closed: 62No prior filing: 35
  • Increased306
  • New123
  • Held128
  • Decreased290
  • Closed62
  • No prior filing35
FilerSharesValueChange
BlackRock, Inc.6.7M$2.49Bincreased
FMR LLC6.0M$2.22Bincreased
VANGUARD CAPITAL MANAGEMENT LLC4.6M$1.71Bdecreased
VANGUARD PORTFOLIO MANAGEMENT LLC4.1M$1.53Bincreased
STATE STREET CORP3.3M$1.23Bdecreased
Artisan Partners Limited Partnership2.0M$744.4Mdecreased
GEODE CAPITAL MANAGEMENT, LLC1.9M$715.2Mincreased
Bank of New York Mellon Corp1.7M$644.7Mdecreased
MORGAN STANLEY1.6M$583.7Mdecreased
T. Rowe Price Investment Management, Inc.1.6M$577.3Mdecreased
Invesco Ltd.1.2M$440.5Mincreased
JPMORGAN CHASE & CO1.1M$414.8Mdecreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by WST insiders, by quarter · Form 4
-20.0K-10.0K010.0K20.0K2025 Q1: 02025 Q12025 Q2: 02025 Q22025 Q3: 02025 Q32025 Q4: 02025 Q42026 Q1: 02026 Q12026 Q2: -3,7132026 Q22026 Q3: -15.7K2026 Q32026 Q4: 02026 Q4

Recent Insider Transactions

2,206 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Favorite Annette FSr. VP & Chief HR Officer Sale −2,524 $365.00 $921K Sep 15, 2026 Form 4 ↗
Favorite Annette FSr. VP & Chief HR Officer Option exercise +2,524 $89.64 $226K Sep 15, 2026 Form 4 ↗
Favorite Annette FSr. VP & Chief HR Officer Sale −2,500 $355.00 $888K Sep 14, 2026 Form 4 ↗
Favorite Annette FSr. VP & Chief HR Officer Option exercise +2,500 $89.64 $224K Sep 14, 2026 Form 4 ↗
Favorite Annette FSr. VP & Chief HR Officer Sale −2,500 $345.00 $863K Sep 11, 2026 Form 4 ↗
Favorite Annette FSr. VP & Chief HR Officer Option exercise +2,500 $89.64 $224K Sep 11, 2026 Form 4 ↗
Favorite Annette FSr. VP & Chief HR Officer Sale −2,500 $340.81 $852K Sep 8, 2026 Form 4 ↗
Favorite Annette FSr. VP & Chief HR Officer Option exercise +2,500 $89.64 $224K Sep 8, 2026 Form 4 ↗
Favorite Annette FSr. VP & Chief HR Officer Sale −2,818 $340.81 $960K Sep 8, 2026 Form 4 ↗
Favorite Annette FSr. VP & Chief HR Officer Option exercise +2,818 $83.47 $235K Sep 8, 2026 Form 4 ↗
Favorite Annette FSr. VP & Chief HR Officer Sale −2,817 $340.81 $960K Sep 8, 2026 Form 4 ↗
Favorite Annette FSr. VP & Chief HR Officer Option exercise +2,817 $83.47 $235K Sep 8, 2026 Form 4 ↗
McMahon Robert W.SVP & Chief Financial Officer Tax withholding −2,764 $351.37 $971K Aug 11, 2026 Form 4 ↗
McMahon Robert W.SVP & Chief Financial Officer Option exercise +6,355 — — Aug 11, 2026 Form 4 ↗
McMahon Robert W.SVP & Chief Financial Officer Tax withholding −346 $351.37 $121K Aug 11, 2026 Form 4 ↗
McMahon Robert W.SVP & Chief Financial Officer Option exercise +794 — — Aug 11, 2026 Form 4 ↗
Campbell Shane AldenSVP, Proprietary Segment Tax withholding −135 $312.07 $42K May 12, 2026 Form 4 ↗
Campbell Shane AldenSVP, Proprietary Segment Option exercise +474 — — May 12, 2026 Form 4 ↗
Campbell Shane AldenSVP, Proprietary Segment Tax withholding −84 $312.07 $26K May 12, 2026 Form 4 ↗
Campbell Shane AldenSVP, Proprietary Segment Option exercise +296 — — May 12, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding WST · SEC Form N-PORT
FundSharesValue% of fundAs of
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
2.2M$805.2M0.04%Jun 30, 2026
VANGUARD 500 INDEX FUND
VANGUARD INDEX FUNDS
1.8M$657.1M0.04%Jun 30, 2026
VANGUARD MID-CAP INDEX FUND
VANGUARD INDEX FUNDS
1.5M$549.5M0.25%Jun 30, 2026
iShares Core S&P 500 ETF
iShares Trust
971.7K$348.8M0.04%Jun 30, 2026
Fidelity Contrafund941.6K$338.0M0.19%Jun 30, 2026
VANGUARD GROWTH INDEX FUND
VANGUARD INDEX FUNDS
940.5K$337.6M0.09%Jun 30, 2026
T. Rowe Price Mid-Cap Growth Fund, Inc.894.8K$321.2M1.39%Jun 30, 2026
Fidelity 500 Index Fund
Fidelity Concord Street Trust
917.1K$312.8M0.04%Aug 31, 2026
State Street(R) SPDR(R) S&P 500(R) ETF Trust856.2K$307.4M0.04%Jun 30, 2026
Strategic Advisers Fidelity U.S. Total Stock Fund
Fidelity Rutland Square Trust II
875.0K$298.5M0.11%Aug 31, 2026

Mutual funds and ETFs whose N-PORT filings list WST's shares (CUSIP 955306105), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 6.0M shares8.5%
    Nov 5, 2026 · ↗
  • FMR LLCSCHEDULE 13G/A · passive (13G) · 6.0M shares8.5%
    Nov 5, 2026 · ↗
  • Abigail P. JohnsonSCHEDULE 13G · passive (13G) · 3.6M shares5.0%
    Aug 6, 2026 · ↗
  • FMR LLCSCHEDULE 13G · passive (13G) · 3.6M shares5.0%
    Aug 6, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming WEST PHARMACEUTICAL SERVICES INC as client

No lobbying filings found naming WEST PHARMACEUTICAL SERVICES INC as the client.

Government Contracts

Federal awards to WEST PHARMACEUTICAL SERVICES INC · USAspending

No federal contract awards found for WEST PHARMACEUTICAL SERVICES INC.

U.S. Patents

Recent USPTO applications naming WEST PHARMACEUTICAL SERVICES INC

No USPTO patent applications found for WEST PHARMACEUTICAL SERVICES INC.

Annual Financials

From WST's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$3.07B$2.89B$2.95B$2.89B$2.83B
Operating income$584.9M$569.9M$676.0M$734.0M$752.3M
Net income$493.7M$492.7M$593.4M$585.9M$661.8M
Diluted EPS$6.79$6.69$7.88$7.73$8.67
Operating cash flow$754.8M$653.4M$776.5M$724.0M$584.0M
Cash and equivalents$791.3M$484.6M$853.9M$894.3M$762.6M
Total assets$4.27B$3.64B$3.83B$3.62B$3.31B
Total liabilities$1.09B$961.1M$948.5M$931.9M$978.4M
Shareholders' equity$3.18B$2.68B$2.88B$2.68B$2.34B

As WEST PHARMACEUTICAL SERVICES INC tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 17, 2026 ↗

Stock Splits

Every split and reverse split in the price history
  • 2-for-1Stock splitSep 27, 2013

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureOct 29, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 1.02, 2.03, 9.01Material agreement · Termination of agreement · Direct financial obligationOct 26, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 7.01, 9.01Results of operations · Reg FD disclosureJul 23, 2026
    EDGAR ↗
  • 8-K · Items 1.01, 9.01Material agreementJul 14, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 7.01, 9.01Officer / director change · Reg FD disclosureJun 1, 2026
    EDGAR ↗
  • 8-K/A · Items 1.05, 9.01May 20, 2026
    EDGAR ↗
  • 8-K · Items 1.05, 7.01, 9.01Reg FD disclosureMay 11, 2026
    EDGAR ↗
  • 8-K · Items 5.07, 9.01Shareholder voteMay 5, 2026
    EDGAR ↗

About WEST PHARMACEUTICAL SERVICES INC

From SEC EDGAR company records
Industry (SIC 3841)Surgical & Medical Instruments & Apparatus
SectorHealthcare
HeadquartersEXTON, PA
IncorporatedPA
Former namesWEST CO INC